TAVR vs isolated SAVR in low-risk patients: 5-year comparative outcomes from the Evolut Low Risk trial
Post hoc subanalysis of the Evolut Low Risk trial comparing 5-year outcomes in 1164 low-risk patients with severe aortic stenosis undergoing isolated aortic valve replacement, either transcatheter (TAVR) or surgical (SAVR).
Beyond TAVI: what the 2025 valvular heart disease guidelines change for cardiac surgeons
A surgeons’ notebook article summarizing the main surgical implications of the 2025 ESC/EACTS guidelines on valvular heart disease and exploring how these recommendations may be translated into daily clinical practice.
Hybrid alternative for postinfarction VSR: the SurCOP strategy
Description and outcomes of a hybrid strategy for the management of postinfarction VSR.
RecoverHeart: estimating myocardial recovery before implanting a ventricular assist device
Multicenter development and external validation study, with a prominent contribution from the Utah group, proposing a calculator to estimate—before implantation—the individual probability of significant reverse remodeling in patients with advanced heart failure treated with a durable left ventricular assist device.
Biological circulatory support: cardiac xenotransplantation as a bridge in infants
Preclinical study of pig-to-baboon cardiac xenotransplantation as a bridge to allotransplantation.
Can a simple angle compromise a coronary bypass graft? The importance of geometry in sequential arterial revascularization
This study examines the impact of the angle formed at the sequential anastomosis to a diagonal branch (D-angle) in patients undergoing total arterial coronary revascularization with different graft configurations. Variations in the width of this angle may compromise flow through the distal segment of the graft.
LVAD vs heart transplantation in middle-aged patients: which treatment should be considered first?
This study aimed to determine which strategy provides the greatest net survival benefit as the initial therapeutic option for middle-aged patients with advanced heart failure: heart transplantation or left ventricular assist device therapy.
A second chance in minimally invasive mitral valve repair?
This study evaluates the safety and short- and mid-term outcomes of performing second aortic cross-clamping (2nd XCL) in patients undergoing minimally invasive mitral valve repair (MI-MVr) when the initial repair does not achieve an acceptable result.
